Drugs / BMS-830216
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 1 | NCT00878020 Comparator | May → Sep 2009 | obesity disorder | Bristol-Myers Squibb | Completed | No outcome recorded |
| Phase 1/2 | NCT00909766 Comparator | Aug 2009 → Jun 2011 | obesity disorder | Bristol-Myers Squibb | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BMS-830216 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00878020 ↗ |
| Modality | Small molecule | — CHEMBL2147475 ↗ |
| Route | Oral | “Capsules, Oral, Single Dose, 1 day” NCT00878020 ↗ |